NASDAQ:SRPT   Sarepta Therapeutics, Inc.
This stock had a stock split without splitting it split about 50% due to bad earnings...it has now found support on the 200 dma. This offers a good entry should you take the risk to buy here. However it may be best to wait until it breaks out to the upside or downside to take a trade long/short. The potential on breakout to upside is back to the 40s could take months but would be a double from here,

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.